financetom
Business
financetom
/
Business
/
Italy's Intesa partners with BlackRock in private banking in Benelux
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Italy's Intesa partners with BlackRock in private banking in Benelux
Nov 11, 2024 6:18 AM

MILAN (Reuters) - Italy's largest bank Intesa Sanpaolo said it would partner with BlackRock ( BLK ), the world's biggest asset manager and a leading Intesa shareholder, to offer digital wealth management services to clients in Belgium and Luxembourg.

By teaming up with BlackRock ( BLK ), Intesa Sanpaolo's private banking unit Fideuram will broaden its digital offering of investments to clients in those two countries, with a view to expanding further in Europe.

"This agreement is a perfect fit with our strategy based on the growth of our wealth management business and the development of new digital solutions," CEO Carlo Messina said.

With a strong focus on its home country, which accounts for the bulk of its profits, Intesa has bet on investments in technology to grow.

It launched last year Fideuram Direct, a digital private banking channel to serve younger customers leveraging technology to compete in a sector where players are increasingly betting on scale to lower costs.

Messina has repeatedly said there are no wealth management targets Intesa could buy at prices that would deliver value for shareholders.

Intesa can't expand domestically due to antitrust limits after buying smaller peer UBI in 2020. A cross-border deal like the possible Commerzbank buy being explored by crosstown rival UniCredit would not provide enough cost cuts without the foreign presence of UniCredit, Messina has said.

Earlier this year Intesa reorganised its core wealth management activities under veteran executive Tommaso Corcos, widely seen as one of the potential successors to CEO Messina in the future.

On Friday, Intesa said it was further simplifying its wealth management divisions.

It said it would have one division within its Eurizon asset management business in charge of funds, and another division within Fideuram in charge of all portfolio management services offered by financial advisors and private bankers.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
May 13, 2024
Monday, Takeda Pharmaceutical Company Limited ( TAK ) and AC Immune SA ( ACIU ) announced an exclusive, worldwide option and license agreement for AC Immune’s active immunotherapies targeting toxic forms of amyloid beta (Abeta), including ACI-24.060 for Alzheimer’s disease. ACI-24.060 is an anti-Abeta active immunotherapy candidate designed to induce an antibody response against the toxic forms of Abeta believed to drive plaque formation and Alzheimer’s...
Why MiNK Therapeutics Stock Is Up 11% Monday
Why MiNK Therapeutics Stock Is Up 11% Monday
May 13, 2024
MiNK Therapeutics, Inc. ( INKT ) shares are trading higher Monday after the clinical-stage biopharmaceutical company announced private placement financing of $5.8 million. What Happened: On Monday, MiNK Therapeutics ( INKT ) entered into a stock purchase agreement to sell securities in a private investment in public equity (PIPE) agreement. MiNK said it will sell 4.64 million shares at a price...
--Street Color: Kraft Heinz Reportedly Mulls Sale of Oscar Mayer
--Street Color: Kraft Heinz Reportedly Mulls Sale of Oscar Mayer
May 13, 2024
01:50 PM EDT, 05/13/2024 (MT Newswires) -- (Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 36.45, Change: +0.21, Percent...
Sanara MedTech Q1 Net Loss Widens, Revenue Increases -- Shares Down
Sanara MedTech Q1 Net Loss Widens, Revenue Increases -- Shares Down
May 13, 2024
01:49 PM EDT, 05/13/2024 (MT Newswires) -- Sanara MedTech ( SMTI ) reported Q1 net loss Monday of $0.21 per diluted share, widening from $0.14 a year earlier. One analyst polled by Capital IQ expected a loss of $0.07. Revenue for the quarter ended March 31 was $18.5 million, up from 15.5 million a year earlier. One analyst surveyed by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved